Tumor Markers
Liver, breast, intestinal, and pancreatic cancers as well as common male and female reproductive cancers, have clinically significant tumor markers used to monitor disease progression. Enzyme immunoassays (EIAs) are the gold standard technology used for the quantitative determination of tumor markers including AFP, CA-125, CA15-3, CA19-9, CEA, PSA and Free PSA.
PSA (Prostate Specific Antigen) ELISA Kit (CE)
The PSA (Prostate Specific Antigen) ELISA Kit is intended for the measurement of prostate specific antigen in a sample. Kit has a lead time of 1 week from order receipt.
Free PSA (Prostate Specific Antigen) ELISA Kit (CE)
The Free PSA ELISA Kit is intended for the measurement of free prostate specific antigen in a sample. Kit has a lead time of 1 week from order receipt.
CEA ELISA Kit (CE)
The CEA ELISA Kit is intended for the measurement of carcinoembryonic antigen in a sample. Kit has a lead time of 1 week from order receipt.
CA 19-9 ELISA Kit (CE)
The CA 19-9 ELISA Kit is intended for the measurement of CA 19-9 in a sample. Kit has a lead time of 1 week from order receipt.
CA 15-3 ELISA Kit (CE)
The CA 15-3 ELISA Kit is intended for the measurement of CA 15-3 (Breast Cancer Antigen) in a sample. Kit has a lead time of 1 week from order receipt.
CA 125 ELISA Kit (CE)
The CA 125 ELISA Kit is intended for the measurement of CA 125 (Ovarian Cancer Antigen) in a sample. Kit has a lead time of 1 week from order receipt.
Beta 2-Microglobulin ELISA Kit
The Beta 2-Microglobulin ELISA Kit is intended for the measurement of Beta 2-Microglobulin in a sample. Kit has a lead time of 1 week from order receipt.
AFP (alpha fetoprotein) ELISA Kit
The AFP ELISA Kit is intended for the measurement of alpha-fetoprotein in a sample. Kit has a lead time of 1 week from order receipt.